Safety of Nanomaterials along Their Lifecycle: Release, Exposure, and Human Hazards

Couverture
Wendel Wohlleben, Thomas A.J. Kuhlbusch, Jürgen Schnekenburger, Claus-Michael Lehr
CRC Press, 3 déc. 2014 - 472 pages

The incorporation of nanomaterials into products can improve performance, efficiency, and durability in various fields ranging from construction, energy management, catalysis, microelectronics, plastics, coatings, and paints to consumer articles such as foods and cosmetics. But innovation never comes at zero risk. The potential hazards resulting from human exposure during production, use, or disposal has raised concerns and targeted research early on.

Safety of Nanomaterials along Their Lifecycle: Release, Exposure, and Human Hazards presents the state of the art in nanosafety research from a lifecycle perspective. Although major knowledge gaps still exist, solid data are now available to identify scenarios of critical risk as well as those of safe nanomaterial use for our benefit.

The book is divided into four parts: characterization, hazard, release and exposure, and real-life case studies. To improve coherence throughout the book, various chapters review the same suite of well-characterized, judiciously chosen, and identical industrial nanomaterials. The book is a helpful resource to professionals in product development, industrial design, regulatory agencies, and materials scientists and engineers involved in the safety of nanomaterials.

 

Avis des internautes - Rédiger un commentaire

Aucun commentaire n'a été trouvé aux emplacements habituels.

Autres éditions - Tout afficher

Expressions et termes fréquents

À propos de l'auteur (2014)

Edited by

Wendel Wohlleben, Advanced Materials and Systems Research, Department of Material Physics, BASF SE, Ludwigshafen, Germany

Thomas A.J. Kuhlbusch, Air Quality and Sustainable Nanotechnology Unit, Institute of Energy and Environmental Technology (IUTA) e.V, Duisburg, Germany

Jürgen Schnekenburger, Biomedical Technology Center, Westfälische Wilhelms-Universität, Münster, Germany

Claus-Michael Lehr, Helmholtz-Institute for Pharmaceutical Research Saarland (HIPS) Helmholtz Centre for Infection Research (HZI) and Department of Biopharmaceutics and Pharmaceutical Technology, Saarland University, Saarbrücken, Germany

Informations bibliographiques